News

Boosting Treatment Success: Insights into How Understanding People Helps Improve Health Habits

Boosting Treatment Success: Insights into How Understanding People Helps Improve Health Habits
BEAMER is delighted to announce its new article now published in Clinical Leader!

BEAMER is delighted to announce that its project lead Claire Everitt, the Device Design and Engineering Team Leader in R&D at Pfizer and Aad R. Liefveld, a project member, have authored an article titled ‘Understanding Human Behavior To Help Improve Patient Adherence‘ published in Clinical Leader.

 

Unveiling the Urgent Context:

 

This article has been published due to the recognition of patient behaviour as a pivotal factor influencing the outcome of a treatment. Despite considerable efforts within the healthcare industry to bolster patient adherence through various means such as improving patient experiences, and fostering collaborative decision-making between healthcare professionals and patients, statistics indicate that these efforts have not substantially impacted adherence rates. This is why the BEAMER project was set up – to help address the persistent issue of low adherence rates in patient treatment and support. It is specifically designed with the aim of enhancing patient support and improving treatment adherence within healthcare systems.

 

The article, accessible here, illuminates the crucial factors that impact treatment adherence in healthcare.

 

Targeting real-world adherence improvements: BEAMER’s main goal is to significantly improve real-world adherence by emphasizing the necessity for stakeholders to embrace a model that goes beyond theory, emphasising simplicity, practicality, proven effectiveness, and reliance on factors that we can influence.

Validated: Validation through clinical studies involving 18,000 patients across six diverse treatment areas aims to establish the model’s effectiveness and disease-agnostic understanding, crucial for its acceptance and implementation as the basis for practical solutions.

Clinical Care and Clinical Research: Non-adherence is considered a greater issue during clinical care than in clinical studies; however, genuine issues also exist in clinical studies. After decades of improving clinical studies, the early dropout rate, across all conditions, is still substantial: up to 30%. Non-adherence therefore has a major effect on timelines, costs, efficacy, and clinical data sets.

 

Where to read the article?

 

If you’re interested in discovering more, then click here to read the full article.

 

Our role at BEAMER:

 

ECHAlliance leads Work Package 6, overseeing communication and dissemination efforts within the project.

NEWS​

Related News

A Shift to Value-Based Procurement in Digital Health Solutions

16 May 2024
The shift towards value-based procurement in healthcare, focusing on long-term effectiveness and patient outcomes, rather than initial costs. The Dire...

Launching Moxiam+: the digital companion for an active and independent senior lifestyle

16 May 2024
Embark on a journey with Sweden-based Moxiam, the vanguard of digital health innovation dedicated to enriching the lives of seniors. Moxiam leverages ...

Romania – Transylvania Digital Health Ecosystem by FreshBlood is ECHAlliance Ecosystem of the Month – May

15 May 2024
This month we are featuring our Transylvania Digital Health Ecosystem by FreshBlood from Romania as our Ecosystem of the Month.

Revolutionising healthcare: how digitisation will transform care in the next 5 years

14 May 2024
On November 5-6, at the 6th Digital Health Society Summit, we'll explore how digitalisation is set to revolutionise healthcare in the next 5 years.

Dermatology from a broader view: mind-body connection

14 May 2024
Mind-body connection is a term that describes a connection between the mental layer and the body and in the case of a skin disease, the skin. Mind-bod...

CARE4DIABETES (C4D): Reducing the burden of non-communicable diseases

14 May 2024
Non-communicable diseases (NCDs) are responsible for 80% of the disease burden in the EU countries and the leading causes of avoidable premature death...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *